IL102473A - 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor - Google Patents

2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor

Info

Publication number
IL102473A
IL102473A IL102473A IL10247392A IL102473A IL 102473 A IL102473 A IL 102473A IL 102473 A IL102473 A IL 102473A IL 10247392 A IL10247392 A IL 10247392A IL 102473 A IL102473 A IL 102473A
Authority
IL
Israel
Prior art keywords
carbons
alkyl
group
alkoxy
hydroxy
Prior art date
Application number
IL102473A
Other languages
English (en)
Other versions
IL102473A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL102473A0 publication Critical patent/IL102473A0/xx
Publication of IL102473A publication Critical patent/IL102473A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL102473A 1991-07-17 1992-07-12 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor IL102473A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17

Publications (2)

Publication Number Publication Date
IL102473A0 IL102473A0 (en) 1993-01-14
IL102473A true IL102473A (en) 1997-07-13

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102473A IL102473A (en) 1991-07-17 1992-07-12 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor

Country Status (22)

Country Link
EP (1) EP0594729A1 (de)
JP (1) JP2571904B2 (de)
KR (1) KR0165003B1 (de)
CN (1) CN1043759C (de)
AU (1) AU655840B2 (de)
BR (1) BR9206272A (de)
CA (1) CA2113568A1 (de)
CZ (1) CZ284133B6 (de)
EG (1) EG20048A (de)
FI (2) FI940192A0 (de)
HU (1) HUT70528A (de)
IE (1) IE922311A1 (de)
IL (1) IL102473A (de)
MX (1) MX9204190A (de)
NO (1) NO180445C (de)
NZ (1) NZ243580A (de)
PL (1) PL169884B1 (de)
PT (1) PT100689B (de)
RU (1) RU2065859C1 (de)
TW (1) TW201732B (de)
WO (1) WO1993002052A1 (de)
ZA (1) ZA925306B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
CZ280669B6 (cs) * 1992-10-30 1996-03-13 Pfizer Inc. Deriváty 3,4-dihydro-2(1H)-chinolonu a farmaceutický prostředek na jejich bázi
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
CA2369695A1 (en) * 1999-04-09 2000-10-19 Manabu Itoh Agent for treating neuropathic pain
WO2001030330A2 (en) 1999-10-29 2001-05-03 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US7217716B2 (en) 2001-02-23 2007-05-15 Merck & Co., Inc. N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
WO2002080928A1 (en) 2001-04-03 2002-10-17 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
CA2507509A1 (en) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
JP2007508288A (ja) * 2003-10-08 2007-04-05 ファイザー株式会社 縮合ラクタム化合物
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (de) * 1989-05-17 1997-03-12 Pfizer Inc. 2-Piperidino-1-alkanol-Derivate als antiischemische Wirkstoffe
DK0554247T3 (da) * 1990-05-10 2000-08-07 Pfizer Neurobeskyttende indolon og beslægtede derivater

Also Published As

Publication number Publication date
IL102473A0 (en) 1993-01-14
NZ243580A (en) 1994-10-26
JPH06504293A (ja) 1994-05-19
BR9206272A (pt) 1995-04-11
ZA925306B (en) 1994-01-17
NO180445C (no) 1997-04-23
KR0165003B1 (en) 1999-01-15
MX9204190A (es) 1993-01-01
CZ284133B6 (cs) 1998-08-12
PT100689B (pt) 1999-06-30
PL169884B1 (pl) 1996-09-30
EP0594729A1 (de) 1994-05-04
HUT70528A (en) 1995-10-30
NO940144D0 (no) 1994-01-14
NO180445B (no) 1997-01-13
AU2322592A (en) 1993-02-23
HU9400136D0 (en) 1994-05-30
FI981956A (fi) 1998-09-11
IE922311A1 (en) 1993-01-27
FI981956A0 (fi) 1998-09-11
JP2571904B2 (ja) 1997-01-16
FI940192A (fi) 1994-01-14
NO940144L (no) 1994-01-14
FI940192A0 (fi) 1994-01-14
WO1993002052A1 (en) 1993-02-04
CN1043759C (zh) 1999-06-23
EG20048A (en) 1997-03-27
PT100689A (pt) 1993-10-29
TW201732B (de) 1993-03-11
CZ400892A3 (en) 1994-03-16
AU655840B2 (en) 1995-01-12
RU2065859C1 (ru) 1996-08-27
CA2113568A1 (en) 1993-02-04
CN1068566A (zh) 1993-02-03

Similar Documents

Publication Publication Date Title
IL102473A (en) 2-(4-hydroxypiperidino)-1- alkanol derivatives, pharmaceutical compositions containing them and certain intermediates therefor
ES8304534A1 (es) "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina".
NO952393D0 (no) Petroleum-mellomdestillatblanding som inneholder et additiv som begrenser avsetningen av paraffiner
FI802583A (fi) Propenylaminer foerfarande foer framstaellning av dessa farmaceutiska kompositioner innehaollande dessa och anvaendningen av dessa som farmaceutiska medel
ES8103020A1 (es) Procedimiento de preparacion de amino-eteres oxidos
FI841181A0 (fi) Nya n-fenyl-n'- cykloalkylalkanoylpiperaziner och foerfarande foer deras framstaellning.
NO990583L (no) Cykliske eterforbindelser som natriumkanalmodulatorer
IE811931L (en) Oxiranes.
IE841659L (en) Allopurinol prodrugs
TR199802253T2 (xx) Alkilaminobenzotiazol ve benzoksazol t�revleri
ES482004A1 (es) Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos.
ES8107001A1 (es) Un metodo de preparar nuevas diaminas
SE8106441L (sv) 2,6-c-dimetyltyrosin?721-d-aminosyra?722-omega-aminokapronsyra-och-gamma-aminosmorsyraderivat av metioninencefalin
NZ218453A (en) Pharmaceutical compositions containing a synergistic mixture of a dihydropyridine derivative and pyridazodiazepine derivative
ES8100802A1 (es) Procedimiento para la preparacion de azolilcetales
EP0379085A3 (de) Phenylalkylamine und diese enthaltende Fungizide
SE7704246L (sv) Desinfektionsmedel
ES8104210A1 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido.
DE69521895D1 (de) Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten
EP0794780A4 (de) Chinazolinon enthaltende arzneimittel und verfahren zu deren verwendung
FI971177A (fi) Bisyklisiä karboksiamideja 5-HT1A-antagonisteina
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
HU9800430D0 (en) New benzenesulfonylamine compounds, process for preparating them and pharmaceutical compositions containing them
JPS5513728A (en) Antistatic polyester composition
ATE17710T1 (de) Keten-0,0-acetale und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees